1, Hais txog LGD-4033
LGD-4033 yog kev xaiv androgen receptor modulator (SARMS), thiab tus tshiab tsis yog tshuaj lub qhov ncauj SARM uas khi rau AR nrog siab sib luag (Ki ntawm ~ 1 nM) thiab xaiv tau. Nws yog tsim los kho cov leeg hlau kom cuam tshuam nrog kev mob qog noj ntshav, mob hnyav thiab mob ntev thiab mob leeg lub hnub nyoog.
LGD-4033 yuav ci dua-yog li yog tias khiav nrog cov SARMS S-4 thiab Cardarine (GW-501516). Qhov no yuav zoo ib yam li SARMS triple stack uas ib txwm khiav nrog Ostarine, tshwj tsis yog muaj peev xwm ntau ntau tau tso rau thaum txiav.
2, Koob Tshuaj
Ib koob tshuaj zoo rau hom no yuav yog 3-5 mg ib hnub twg rau 8 lub lis piam.
3, Cov khoom lag luam ntsig txog peb muab
Ostarine, MK-2866, Enobosarm Enobosarm (Ostarine, MK-2866, GTx-024) - cuam tshuam ob qho tib si rau cov leeg thiab pob txha, npaj feem ntau rau cov mob txha caj qaum tab sis kuj tseem kho tau dav rau andropause thiab thim rov qab cov leeg mob sarcopenia hauv cov neeg laus thiab rau cachexia hauv cov neeg mob cancer.
LGD-4033 pharmacological cov ntaub ntawv zoo ib yam li enobosarm, Ostarine, MK-2866
Andarine (S-4) ib nrab agonist, npaj rau feem ntau rau kev kho mob benign prostatic hypertrophy
GW-501516 Nws tau raug kuaj raws li kev tuaj yeem kho kev rog, mob ntshav qab zib, dyslipidemia thiab kab mob plawv
AICAR AICAR ua los ntawm kev nkag mus hauv pas dej nucleoside, nce ntau ntawm adenosine thaum lub sijhawm ATP tawg.
4.What yog LGD-4033?
LGD-4033 yog kev xaiv androgen receptor modulator (SARMS), thiab tus tshiab tsis yog tshuaj lub qhov ncauj SARM uas khi rau AR nrog siab sib luag (Ki ntawm ~ 1 nM) thiab xaiv tau. Nws nyob hauv chav kawm ntawm androgen receptor (AR) ligands uas yog cov ntaub so ntswg xaiv, tsim los kho cov leeg txhaws cuam tshuam nrog kev mob qog noj ntshav, mob hnyav thiab mob ntev thiab mob ntsig txog lub hnub nyoog. LGD-4033 cia siab tias yuav tsim cov txiaj ntsig kev ntsuas ntawm kev sim nrog kev nyab xeeb zoo dua, kev tiv thaiv siab thiab kev lees txais tus neeg mob vim kev xaiv cov ntaub so ntswg ntawm kev ua thiab qhov ncauj ntawm kev tswj hwm.
5.How nws ua haujlwm
LGD-4033, tus tshiab tshiab tsis tshaj tawm, lub qhov ncauj xaiv qhov androgen receptor modulator, khi rau androgen receptor nrog siab sib raug zoo thiab xaiv xaiv. Nws ua kom pom qhov kev ua haujlwm anabolic hauv cov leeg nqaij, los tiv thaiv resorptive thiab anabolic kev ua haujlwm hauv cov pob txha thiab ib qho kev xaiv zoo rau cov leeg thiab pob txha tiv thaiv prostate thiab qog sebaceous. LGD-4033 tsis ntev los no tau ua tiav Theem I Ntau Ascending Koob Tshawb Fawb rau cov neeg ua haujlwm pab dawb. Qhov kev xaiv ob qho tib si, dig muag ob qhov muag, tshuaj placebo Ntu I kawm tsim kev nyab xeeb thiab tiv taus kom txog li ntawm 22 mg ib hnub twg.
Cim npe nrov: ntshiab qhov ncauj sarms cov tshuaj hormones hmoov lgd 4033 rau kev tsim kho lub cev, Tuam Tshoj, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, cov nqi teev, hauv Tshuag, cov qauv dawb
